Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort
The invasive coral Oculina patagonica has not been recently introduced to the Mediterranean from the western Atlantic
Magkos F, Fabbrini E, Mohammed BS, Patterson BW, Klein S (2010) Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction
Obesity itself is one of the most underrecognized causes of low milk supply, working through several mechanisms: excess fat tissue slows the hormonal shift that "turns on" full milk production after delivery, high leptin levels interfere with prolactin response, and insulin resistance (extremely common in obesity) disrupts the metabolic signaling your mammary gland needs to produce milk efficiently
Lixisenatide slows gastric emptying which may affect the absorption of other medications
Tirzepatide a dual-action medication that supports appetite control and metabolic balance
.png)
